| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.5B | $14.9B | $14.6B | $14.2B | $12.7B | $10.6B | $8.4B | — |
| Cost of Revenue | $9.9B | $9.5B | $9.3B | $9.2B | $8.3B | $6.9B | $5.5B | — |
| Gross Profit | $5.7B | $5.4B | $5.2B | $5.0B | $4.5B | $3.8B | $2.9B | $2.7B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.7B | $3.5B | $3.4B | $3.2B | $2.9B | $2.5B | $1.9B | $1.8B |
| Operating Income | $1.5B | $1.5B | $1.5B | $1.4B | $1.3B | $1.0B | $0.7B | $0.7B |
| Net Income | $1.1B | $1.1B | $1.1B | $1.1B | $1.0B | $0.7B | $0.6B | $0.5B |
| EPS (Basic) | $2.07 | $2.05 | $10.15 | $9.78 | $8.69 | $6.44 | $4.70 | $4.34 |
| EPS (Diluted) | $2.06 | $2.04 | $10.09 | $9.71 | $8.61 | $6.38 | $4.66 | $4.31 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.9B | $9.8B | $9.2B | $8.5B | $7.8B | $7.0B | $5.3B | $3.1B |
| Current Assets | $3.5B | $3.3B | $3.3B | $3.2B | $3.3B | $3.3B | $1.8B | $1.8B |
| Cash & Equivalents | $0.2B | $0.3B | $0.4B | $0.2B | $0.9B | $1.3B | $0.1B | $0.1B |
| Total Liabilities | $8.4B | $7.5B | $7.0B | $6.4B | $5.8B | $5.1B | $3.7B | $1.5B |
| Current Liabilities | $2.6B | $2.3B | $2.2B | $2.4B | $2.1B | $1.7B | $1.2B | $0.9B |
| Stockholders' Equity | $2.6B | $2.3B | $2.1B | $2.0B | $2.0B | $1.9B | $1.6B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.6B | $1.4B | $1.3B | $1.4B | $1.1B | $1.4B | $0.8B | $0.7B |
| Investing Cash Flow | $-0.8B | $-0.6B | $-0.7B | $-1.1B | $-0.6B | $-0.3B | $-0.2B | $-0.3B |
| Capital Expenditures | $0.9B | $0.8B | $0.8B | $0.8B | $0.6B | $0.3B | $0.2B | $0.3B |
| Financing Cash Flow | $-0.9B | $-0.9B | $-0.5B | $-0.9B | $-1.0B | $0.2B | $-0.6B | $-0.4B |